You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

This biotech stock has plummeted over the past year. RBC sees big turnaround ahead ⊕

found 2026 › Jan › 21 (Wed) @ 13:06 UTC

a story from CNBC ⚠️ › Top News

RBC's $22 price target implies an upside of 74% for shares of Biohaven.